Human Thalamus in Propagation of Temporal Lobe Seizures and Memory Formation
2 other identifiers
interventional
100
1 country
1
Brief Summary
The goal of the study is to examine how two key subregions of the human thalamus (ANT and PLV) are connected with other brain structures (Aim 1), how seizures involve the two thalamic subregions differently and how the map of cortico-thalamic ictal propagation matches the intrinsic connectivity maps identified in the same individuals (Aim 2), and the effect of ANT and PLV stimulations on memory formation (Aim 3).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 11, 2025
CompletedFirst Posted
Study publicly available on registry
November 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2029
November 12, 2025
August 1, 2025
4.9 years
August 11, 2025
November 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Cerebro-cerebral evoked potentials
To map thalamocortical and corticothalamic causal effective connectivity, the study team will use the well-known method of repeated single electrical pulse stimulation with intracranial EEG. Study team will measure the amplitude and timing to first peak of cerebro-cerebral evoked potentials (CCEPs).
During experiment up to 2 weeks
fMRI BOLD activity
To map thalamocortical and corticothalamic functional connectivity, he study team will obtain 8 runs of 6mins resting state fMRIs. Study team will measure the correlation of BOLD activity across voxels of interest.
During experiment up to 2 weeks
Epileptogenicity Index (EI)
The study team will identify seizure onset zones (SOZs) using the measure of Epileptogenicity Index (EI) applied to data collected through intracranial EEG, and will label the SOZs as medial temporal lobe epilepsy (mTLE) versus nonmedial TLEs.
During experiment up to 2 weeks
Seizure propagation
Seizure propagation to ANT and PLV will be examined through intracranial EEG data within individuals by measuring EI and the propagation latencies from SOZ to ANT and PLV recording sites will be noted.
During experiment up to 2 weeks
Coordinated activity across HPC and ANT
Successful memory encoding is associated with coordinated activity across hippocampus (HPC) and ANT (i.e., high frequency activity in ANT locked to the phase of hippocampal theta). Using intracranial EEG data, the study team will follow traditional analyses of changes in power in the canonical EEG bands (e.g., 3-7 Hz, theta band, 40-150 Hz, high gamma, etc.) as well as computationally derived aperiodic features of the signal \[i.e., using the fitting oscillations \& one over f (FOOOF) function\]. Response onset latency of neural activity will determine with simultaneous recordings across HPC, ANT, and PLV how each ROI is engaged in time during a given experimental condition (i.e., encoding trials later recalled and trials not later recalled). We will also use validated methods of phase amplitude coupling (PAC) and intersite phase coherence (ISPC) to quantify cross regional relationships.
During experiment up to 2 weeks
Cognitive task performance
In total, each patient will be asked to encode 200 words across the 5 sessions.
During experiment up to 2 weeks
Study Arms (1)
Epilepsy Patients with Thalamic Electrode Implants
OTHERPatients will undergo cognitive testing and electrical stimulation experiments.
Interventions
Record brain activity during memory encoding
Measure accuracy and reaction time during cognitive tasks
Eligibility Criteria
You may qualify if:
- No medical or surgical contraindication to electrode implantation
- Patient capable of understanding the scope of our project or signing informed consent independently
You may not qualify if:
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Hospital
Stanford, California, 94304, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Josef Parvizi, MD PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurology and Neurological Sciences (Adult Neurology)
Study Record Dates
First Submitted
August 11, 2025
First Posted
November 12, 2025
Study Start
September 1, 2024
Primary Completion (Estimated)
August 1, 2029
Study Completion (Estimated)
August 1, 2029
Last Updated
November 12, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Within 2 years
Once data collection and analysis for a Specific Aim is complete, we will share our data.